OR1J1 inhibitors represent a class of chemical compounds designed to modulate the function of the OR1J1 receptor, a member of the olfactory receptor family. Olfactory receptors, including OR1J1, belong to the large family of G-protein-coupled receptors (GPCRs) that are predominantly involved in the detection of odor molecules. These receptors, embedded in the membranes of sensory neurons, are known to initiate signal transduction pathways by activating G-proteins, which, in turn, trigger intracellular second messenger cascades. OR1J1 specifically is involved in recognizing and responding to particular volatile chemical ligands, likely contributing to the broader complexity of olfactory perception. Inhibition of OR1J1 may interfere with its capacity to bind its natural ligands, thus altering the signal transduction processes it governs within olfactory systems.
From a chemical perspective, OR1J1 inhibitors typically act by binding to the active site or orthosteric binding domain of the receptor. This form of inhibition can block the receptor's ability to interact with its natural ligand, preventing the necessary conformational changes that allow for G-protein activation. Some inhibitors may also act allosterically, binding at a site distinct from the active site, causing changes in receptor structure that reduce the receptor's overall functionality. The molecular design of OR1J1 inhibitors is often predicated on structural studies of the receptor, with a focus on identifying key interaction points that can be targeted to modify receptor activity. The efficacy of these inhibitors is contingent on factors such as receptor binding affinity, selectivity for OR1J1 over other olfactory receptors, and their stability under physiological conditions. These aspects are of critical importance in studying how these molecules influence olfactory signal transduction at a biochemical and molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Menthol | 89-78-1 | sc-250299 sc-250299A | 100 g 250 g | $39.00 $68.00 | ||
A compound known to modulate GPCR function, which can alter OR1J1 signaling by changing membrane fluidity or receptor conformation. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
A vanilloid that can influence GPCR signaling and may alter OR1J1 activity indirectly through changes in intracellular calcium levels. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Acts as a non-selective blocker of calcium channels, which can indirectly inhibit OR1J1 signaling by modifying intracellular calcium. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
A non-selective antagonist of G protein-coupled purinergic receptors, can inhibit OR1J1 signaling indirectly by altering purinergic signaling pathways. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
Modulates the fluidity of the lipid bilayer, which can affect the conformation and function of GPCRs like OR1J1. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
A sodium channel blocker that can indirectly influence GPCR signaling, possibly affecting OR1J1 activity by modifying neuronal excitability. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A beta-adrenergic blocker that can influence GPCR signaling, potentially affecting OR1J1 activity indirectly by modulating adrenergic pathways. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
A modulator of IP3 receptors, can affect GPCR signaling, thus possibly influencing OR1J1 signaling by altering calcium release. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Known as a CYP3A4 enzyme inhibitor, can influence GPCR signaling by altering metabolism, potentially affecting OR1J1. | ||||||
Diphenhydramine hydrochloride | 147-24-0 | sc-204729 sc-204729A sc-204729B | 10 g 25 g 100 g | $52.00 $84.00 $124.00 | 4 | |
An antihistamine that can indirectly influence GPCR signaling, which may affect OR1J1 activity by modulating histamine pathways. | ||||||